HealthQuill Experimental drug
Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered company has halted its trials.
Drugs Health Pharma

Sage Therapeutics halts trials of experimental drug to treat dementia

Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered.

Read More
Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results
Drugs Health Medical

J&J stops trials on drug to treat muscle-invasive bladder cancer

Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results

Read More
Gilead Sciences, Inc. has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical makers to make and sell its generic lenacapavir drug for the prevention of HIV.
Drugs Health Pharma

Gilead signs six global pacts to make, sell generic HIV preventive drug

Gilead Sciences, Inc. has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical makers to make and sell its generic lenacapavir drug for the prevention.

Read More
Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set goals, according to a NASDAQ filing.
Drugs Health Pharma

Merck’s Keytruda experimental gastric cancer drug flops in one of set goals

HQ Team June 20, 2023: Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set.

Read More